Intech Investment Management LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 25.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,261 shares of the company's stock after buying an additional 13,833 shares during the period. Intech Investment Management LLC owned approximately 0.06% of Clorox worth $10,051,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Clorox by 0.4% during the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after buying an additional 65,924 shares during the period. Northern Trust Corp boosted its stake in shares of Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock worth $225,133,000 after buying an additional 34,655 shares during the period. Invesco Ltd. boosted its stake in shares of Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock worth $200,512,000 after buying an additional 94,371 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company's stock worth $170,406,000 after buying an additional 41,485 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Clorox by 12.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,115,772 shares of the company's stock worth $181,213,000 after buying an additional 123,200 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.
Insider Activity
In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.57% of the company's stock.
Clorox Price Performance
CLX stock opened at $123.35 on Thursday. The firm has a 50 day moving average of $124.30 and a 200-day moving average of $132.88. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market cap of $15.09 billion, a price-to-earnings ratio of 18.92, a PEG ratio of 1.01 and a beta of 0.52.
Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. During the same period last year, the firm earned $1.82 EPS. The company's revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. Clorox's payout ratio is 76.07%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on CLX shares. Barclays decreased their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research note on Tuesday, July 15th. JPMorgan Chase & Co. lifted their price objective on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a report on Monday. Jefferies Financial Group lowered their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Wells Fargo & Company lowered their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday, September 5th. Finally, UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Reduce" and an average price target of $142.18.
View Our Latest Research Report on CLX
About Clorox
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report